Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance ; volume:6 ; number:7 ; year:2019 ; extent:16
Advanced science ; 6, Heft 7 (2019) (gesamt 16)
- Urheber
-
Liu, Jia
Chang, Bingcheng
Li, Qilin
Xu, Luming
Liu, Xingxin
Wang, Guobin
Wang, Zheng
Wang, Lin
- DOI
-
10.1002/advs.201801987
- URN
-
urn:nbn:de:101:1-2022081306180905062916
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Jia
- Chang, Bingcheng
- Li, Qilin
- Xu, Luming
- Liu, Xingxin
- Wang, Guobin
- Wang, Zheng
- Wang, Lin
Ähnliche Objekte (12)
Cancer Chemotherapy: Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance (Adv. Sci. 7/2019)
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinitocan-drug eluting beads
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer
Correction to: Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells
Cancer Chemotherapy: Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance (Adv. Sci. 7/2019)
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinitocan-drug eluting beads
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer
Correction to: Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells
Cancer Chemotherapy: Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance (Adv. Sci. 7/2019)
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinitocan-drug eluting beads
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer